2(4) Factorial Design Formulation Optimization and In vitro Characterization of Desloratadine Nanosuspension Prepared Using Antisolvent Precipitation.
- DOI
- 10.2174/0115672018312715240604054857
- Published
- 2025
- Container
- Current drug delivery
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/0115672018312715240604054857,
title = {2(4) Factorial Design Formulation Optimization and In vitro Characterization of Desloratadine Nanosuspension Prepared Using Antisolvent Precipitation.},
author = {Elsebay MT and Alyami MH and Alyami HS and Kamal MA and Eissa NG and Balata GF and El-Nahas HN},
year = {2025},
journal = {Current drug delivery},
doi = {10.2174/0115672018312715240604054857},
url = {https://doi.org/10.2174/0115672018312715240604054857}
}RIS
TY - JOUR TI - 2(4) Factorial Design Formulation Optimization and In vitro Characterization of Desloratadine Nanosuspension Prepared Using Antisolvent Precipitation. AU - Elsebay MT AU - Alyami MH AU - Alyami HS AU - Kamal MA AU - Eissa NG AU - Balata GF AU - El-Nahas HN PY - 2025 JO - Current drug delivery DO - 10.2174/0115672018312715240604054857 UR - https://doi.org/10.2174/0115672018312715240604054857 ER -
APA
MT, E., MH, A., HS, A., MA, K., NG, E., GF, B., & HN, E. (2025). 2(4) Factorial Design Formulation Optimization and In vitro Characterization of Desloratadine Nanosuspension Prepared Using Antisolvent Precipitation.. Current drug delivery. https://doi.org/10.2174/0115672018312715240604054857
Source records
- pubmed · retrieved 2026-09-26T07:26:35.043Z